TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort

左旋甲状腺素 医学 背景(考古学) 内科学 纵向研究 内分泌学 激素 甲状腺 前瞻性队列研究 血红蛋白 重复措施设计 生物 数学 古生物学 病理 统计
作者
Matthew D Ettleson,Gustavo Penna,Wen Wan,Isabela M. Benseñor,Neda Laiteerapong,Antônio C. Bianco
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
卷期号:109 (12): 3065-3075 被引量:2
标识
DOI:10.1210/clinem/dgae294
摘要

Abstract Context Thyroid-stimulating hormone (TSH) trajectory classification represents a novel approach to defining the adequacy of levothyroxine (LT4) treatment for hypothyroidism over time. Objective This is a proof of principle study that uses longitudinal clinical data, including thyroid hormone levels from a large prospective study to define classes of TSH trajectories and examine changes in cardiovascular (CV) health markers over the study period. Methods Growth mixture modeling (GMM), including latent class growth analysis (LCGA), was used to classify LT4-treated individuals participating in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) based on serial TSH levels. Repeated measure analyses were then utilized to assess within-class changes in blood pressure, lipid levels, hemoglobin A1c, and CV-related medication utilization. Results From the 621 LT4-treated study participants, the best-fit GMM approach identified 4 TSH trajectory classes, as defined by their relationship to the normal TSH range: (1) high–high normal TSH, (2) normal TSH, (3) normal to low TSH, and (4) low to normal TSH. Notably, the average baseline LT4 dose was lowest in the high–high normal TSH group (77.7 µg, P < .001). There were no significant differences in CV health markers between the classes at baseline. At least 1 significant difference in CV markers occurred in all classes, highlighted by the low to normal class, in which total and high-density lipoprotein cholesterol, triglycerides, and A1c all increased significantly (P = .049, P < .001, P < .001, and P = .001, respectively). Utilization of antihypertensive, antihyperlipidemic, and antidiabetes medications increased in all classes. Conclusion GMM/LCGA represents a viable approach to define and examine LT4 treatment by TSH trajectory. More comprehensive datasets should allow for more complex trajectory modeling and analysis of clinical outcome differences between trajectory classes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Xide完成签到,获得积分10
刚刚
星辰大海应助hhdfgif采纳,获得10
1秒前
snail完成签到,获得积分10
2秒前
forest发布了新的文献求助10
2秒前
独享属于自己的风完成签到,获得积分10
2秒前
行云终于谁同完成签到,获得积分10
4秒前
5秒前
5秒前
ljscjth完成签到,获得积分10
7秒前
7秒前
秦始皇完成签到,获得积分20
7秒前
8秒前
acommonreader发布了新的文献求助10
8秒前
完美世界应助咩咩羊采纳,获得10
8秒前
沈言应助guo采纳,获得10
9秒前
9秒前
张志迪发布了新的文献求助10
9秒前
9秒前
Justin发布了新的文献求助10
10秒前
10秒前
淡然平蓝发布了新的文献求助10
10秒前
xieqq00完成签到,获得积分10
11秒前
独特乘云发布了新的文献求助10
12秒前
Pweni举报Eva求助涉嫌违规
12秒前
acommonreader完成签到,获得积分10
13秒前
14秒前
caitSith完成签到,获得积分10
14秒前
14秒前
ibigbird发布了新的文献求助10
15秒前
咕咕完成签到,获得积分10
16秒前
所所应助zixian采纳,获得10
17秒前
余白薇发布了新的文献求助10
17秒前
19秒前
CipherSage应助张志迪采纳,获得10
19秒前
123应助加菲丰丰采纳,获得20
19秒前
永远的爱坤完成签到,获得积分10
20秒前
20秒前
小mol仙完成签到,获得积分10
20秒前
CipherSage应助狂野世立采纳,获得10
21秒前
正直草丛完成签到,获得积分10
21秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
Near Infrared Spectra of Origin-defined and Real-world Textiles (NIR-SORT): A spectroscopic and materials characterization dataset for known provenance and post-consumer fabrics 610
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 600
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
Shining Light on the Dark Side of Personality 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3308821
求助须知:如何正确求助?哪些是违规求助? 2942188
关于积分的说明 8507596
捐赠科研通 2617188
什么是DOI,文献DOI怎么找? 1429994
科研通“疑难数据库(出版商)”最低求助积分说明 663969
邀请新用户注册赠送积分活动 649186